Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor many people, food noise quietens within the first one to four weeks of starting Mounjaro. Some notice it within days of their first dose; others find it settles gradually across the early titration period. The speed depends on your starting dose, your individual response, and how your body adapts to tirzepatide's dual action on appetite-regulating hormones. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Food noise is the term many patients use for the persistent, intrusive mental preoccupation with food: thinking about the next meal before the current one is finished, feeling driven to eat despite not being physically hungry, or finding cravings difficult to push aside. It is not a character flaw. It reflects how appetite-regulating hormones and brain reward circuits interact, and that is precisely the mechanism tirzepatide acts on.
As a dual GIP and GLP-1 receptor agonist, Mounjaro works on two gut-hormone pathways simultaneously. GLP-1 receptor activation signals fullness to the brain and slows the rate at which food leaves the stomach. GIP receptor activation appears to influence how the brain's reward system responds to food. Together, these effects reduce both the physical drive to eat and, for many people, the mental pull towards food. That dual action is part of why tirzepatide's appetite-suppressing effects are described as particularly pronounced in clinical reporting. The NHS patient information on tirzepatide covers how the medicine works alongside its side-effect profile.
A question our prescribers hear most weeks is whether the quietening of food noise feels sudden or gradual. The honest answer is: both happen. Some people describe a noticeable shift within two or three days of their first injection, and if you want to understand how quickly Mounjaro starts to work across those earliest days, our dedicated page walks through what to expect. Others say the change crept up on them over the first fortnight. Neither pattern is wrong.
The real decision most people face is whether a muted response on the starter dose means Mounjaro is not working for them, or whether they simply need more time, or a higher dose, to see the full effect. This is worth understanding before you begin.
Treatment starts at 2.5mg. The first pen's job is to let your body adjust, to reduce the likelihood of nausea and other gastrointestinal effects that can occur when tirzepatide is introduced. Appetite suppression at this level exists but tends to be modest. Most people move to 5mg after four weeks, and many report a noticeably stronger reduction in food noise at that point. Subsequent increases to 7.5mg, 10mg, and beyond often deepen the effect further.
This matters for expectation-setting. If you are three weeks into your first pen and food noise feels only slightly quieter, that is consistent with how quickly Mounjaro works through its titration stages, not evidence that it will not work for you. If you want a broader sense of how quickly Mounjaro works for weight loss, our dedicated page covers the full picture from first dose to steady state. For those wondering specifically about how quickly Mounjaro kicks in after each injection, that page addresses the earliest phase in detail.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, found that participants on tirzepatide reported significant reductions in appetite and caloric intake from the early weeks, with effects on body weight becoming measurable by week four and accelerating thereafter. Results at 15mg reached around 20–21% average body-weight reduction over 72 weeks.
Individual response to tirzepatide varies, and several factors shape the timeline. Metabolic rate, body composition, baseline levels of hunger hormones, and how quickly your system absorbs and processes the medicine all play a role. People with higher baseline appetite or stronger food-reward responses sometimes report a more dramatic early shift; others experience a quieter, steadier reduction.
Stress, sleep quality, and diet composition also matter. Tirzepatide reduces appetite, but it does not eliminate every environmental or emotional trigger for eating. Someone under significant work pressure or sleeping poorly may find food noise persists longer even as the medicine reaches effective levels. This is not a failure of the treatment, it is a reminder that the medicine works best alongside broader lifestyle changes, as the prescribing guidance makes clear.
How consistently you take Mounjaro on the same day each week also affects continuity of effect. Missing doses or irregular injection timing can create gaps in the medicine's action. If you are curious about what happens when a dose is delayed, how quickly Mounjaro wears off explains the pharmacokinetics. Any missed-dose decisions should be guided by your prescriber and the Patient Information Leaflet.
For context on what treatment costs and what is included in a private prescription, the Mounjaro cost guide sets out the market honestly. And if you are still exploring whether an injectable or another licensed option suits you better, our treatment overview compares what is available.
If you are four to six weeks into treatment and have noticed no reduction in appetite or food preoccupation, tell your prescriber. Do not increase your dose yourself or extend the injection interval. There may be a straightforward explanation (including whether the injection technique or storage conditions are correct) or your prescriber may want to review your titration schedule.
Side effects during the early weeks are worth monitoring too. Nausea is common, particularly after dose increases, and can temporarily make it harder to distinguish between reduced appetite and food aversion. The NICE appraisal of tirzepatide (TA1026) notes that treatment should be reviewed if meaningful weight loss is not achieved at the highest tolerated dose by six months, a clinical benchmark, not a reason to panic in week three.
If you are considering starting Mounjaro or want to understand more about your options, check your eligibility with our clinical team. Every consultation is reviewed by a GPhC-registered Independent Prescriber, the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.